Aldeyra Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 16 U.S.-traded ETFs. ALDX has around 1.2M shares in the U.S. ETF market. The largest ETF holder of ALDX is the Vanguard Total Stock Market ETF (VTI), with approximately 372.45K shares. Investors may also find of interest that the ETF with the largest allocation to ALDX stock is Invesco NASDAQ Future Gen 200 ETF (QQQS), with a portfolio weight of 0.66%. On average, U.S. ETFs allocate 0.13% of ALDX to their portfolios.
Additionally, ALDX is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALDX as a holding is the Dimensional U.S. Targeted Value ETF (DFAT), with a return of 1.68%.